Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
166.41 USD
1.06%
Market Closed
Updated:
Apr 20, 2024
Abbvie Inc
Accumulated Depreciation
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Accumulated Depreciation Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Accumulated Depreciation
$-6.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Accumulated Depreciation?
Accumulated Depreciation
-6.6B
USD
-6.6B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Accumulated Depreciation amounts to -6.6B USD.
What is Abbvie Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 10Y
-4%
-4%
Over the last year, the Accumulated Depreciation growth was -10%. The average annual Accumulated Depreciation growth rates for Abbvie Inc have been -6% over the past three years , -4% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
